A potential clinical use for methylphenidate with tricyclic antidepressants.
D000328:Adult; D000368:Aged; D000818:Animals; D002697:Chloral Hydrate / Q000627:therapeutic use; D002855:Chromatography, Thin Layer; D003863:Depression / Q000188:drug therapy* / Q000201:enzymology; D003891:Desipramine / Q000037:antagonists & inhibitors / Q000097:blood / Q000627:therapeutic use*; D003913:Dextroamphetamine / Q000378:metabolism; D004357:Drug Synergism; D004565:Electroconvulsive Therapy; D005260:Female; D000882:Haplorhini; D006801:Humans; D007099:Imipramine / Q000037:antagonists & inhibitors / Q000097:blood / Q000627:therapeutic use*; D008099:Liver / Q000378:metabolism; D008297:Male; D008774:Methylphenidate / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D008875:Middle Aged; D011613:Psychotherapy; D051381:Rats
D008774:Methylphenidate; D002697:Chloral Hydrate; D007099:Imipramine; D003891:Desipramine; D003913:Dextroamphetamine